Nousheen Aziz1, Sajida Yousfani2. 1. Dr. Nousheen Aziz, MS, Senior Registrar, Department of Gynaecology & Obstetrics, Liaquat University of Medical & Health Sciences, Jamshoro, Sindh, Pakistan. 2. Dr. Sajida Yousfani, FCPS, Associate Professor, Department of Gynaecology & Obstetrics, Liaquat University of Medical & Health Sciences, Jamshoro, Sindh, Pakistan.
Abstract
OBJECTIVE: To find the pattern of presentation of cervical carcinoma as seen at Nuclear Institute of Medicine and Radiotherapy, Pakistan. METHODOLOGY: This retrospective descriptive study was conducted at the Nuclear Institute of Medicine and Radiotherapy (NIMRA) for a period of one year from January 1(st) to December 31(st), 2009. The clinical records of all patients diagnosed with carcinoma of the cervix were reviewed with regard to sociodemographic and reproductive parameters. Frequency of cervix and stage of disease at time of presentation were recorded. The data was collected on pre-designed proforma and analysed using SPSS Version 16 statistical package. Results : There were a total of 56 cases (33.53%) of carcinoma of cervix who presented at NIMRA during the study period. The mean age was 51 years. Irregular vaginal bleeding, foul smelling vaginal discharge and post coital bleeding were the most common symptoms. Squamous cell carcinoma corresponds to 52 (92.85%) and adeno carcinoma to 4 (7.14%) cases. Only 8(14.28%) cases were in Stage I, while 20(35.71%), 22(39.28%) were in Stages II and Stage III respectively whilst 6(10.71%) cases were in advanced stage (1V). CONCLUSION: Squamous cell carcinoma accounted for 92.85% of cases with mean age of 51 years, most patients 74.98% presented in stage II, III and IV. Diagnosis at advanced stage needs implementation of large scale educational and screening programme on national level to saves the lives of Pakistani women.
OBJECTIVE: To find the pattern of presentation of cervical carcinoma as seen at Nuclear Institute of Medicine and Radiotherapy, Pakistan. METHODOLOGY: This retrospective descriptive study was conducted at the Nuclear Institute of Medicine and Radiotherapy (NIMRA) for a period of one year from January 1(st) to December 31(st), 2009. The clinical records of all patients diagnosed with carcinoma of the cervix were reviewed with regard to sociodemographic and reproductive parameters. Frequency of cervix and stage of disease at time of presentation were recorded. The data was collected on pre-designed proforma and analysed using SPSS Version 16 statistical package. Results : There were a total of 56 cases (33.53%) of carcinoma of cervix who presented at NIMRA during the study period. The mean age was 51 years. Irregular vaginal bleeding, foul smelling vaginal discharge and post coital bleeding were the most common symptoms. Squamous cell carcinoma corresponds to 52 (92.85%) and adeno carcinoma to 4 (7.14%) cases. Only 8(14.28%) cases were in Stage I, while 20(35.71%), 22(39.28%) were in Stages II and Stage III respectively whilst 6(10.71%) cases were in advanced stage (1V). CONCLUSION:Squamous cell carcinoma accounted for 92.85% of cases with mean age of 51 years, most patients 74.98% presented in stage II, III and IV. Diagnosis at advanced stage needs implementation of large scale educational and screening programme on national level to saves the lives of Pakistani women.
Entities:
Keywords:
Cervical cancer; Frequency; Stage at diagnosis
Authors: P Laikangbam; S Sengupta; P Bhattacharya; C Duttagupta; Th Dhabali Singh; Y Verma; S Roy; R Das; S Mukhopadhyay Journal: Int J Gynecol Cancer Date: 2007 Jan-Feb Impact factor: 3.437
Authors: Sardar Zakariya Imam; Fatima Rehman; Malik Muhammad Zeeshan; Bilal Maqsood; Sameen Asrar; Noor Fatima; Fawad Aslam; Muhammad Rizwanul Haq Khawaja Journal: Asian Pac J Cancer Prev Date: 2008 Jan-Mar
Authors: Rūta Grigiene; Konstantinas P Valuckas; Eduardas Aleknavicius; Juozas Kurtinaitis; Simona R Letautiene Journal: BMC Cancer Date: 2007-12-22 Impact factor: 4.430
Authors: Vincent Vinh-Hung; Claire Bourgain; Georges Vlastos; Gábor Cserni; Mark De Ridder; Guy Storme; Anne-Thérèse Vlastos Journal: BMC Cancer Date: 2007-08-23 Impact factor: 4.430